0
0
0
Fair Accountability and Innovative Research Drug Pricing Act of 2023
12/15/2023, 4:06 PM
Congressional Summary of S 935
Fair Accountability and Innovative Research Drug Pricing Act of 2023
This bill requires manufacturers to report about certain price increases for prescription drugs and biological products with a wholesale cost of at least $100 per month.
Such reports must include, among other information (1) the percentage price increase, (2) a justification for such increase, (3) the price history of the drug, (4) the total cost to develop the drug, and (5) the total revenue and net profit generated from the drug. Manufacturers are subject to civil penalties for failing to comply with the bill's requirements. Additionally, the Food and Drug Administration must post the information on its website.
Current Status of Bill S 935
Bill S 935 is currently in the status of Bill Introduced since March 22, 2023. Bill S 935 was introduced during Congress 118 and was introduced to the Senate on March 22, 2023. Bill S 935's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 22, 2023
Bipartisan Support of Bill S 935
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 935
Primary Policy Focus
HealthComments
Sponsors and Cosponsors of S 935
Latest Bills
Biodefense Diplomacy Enhancement Act
Bill HR 7653April 17, 2026
Supporting the designation of the week of April 20 through April 24, 2026, as "National Home Visiting Week".
Bill HRES 1171April 17, 2026
Expressing support for the designation of April 2026 as "Second Chance Month".
Bill HRES 1173April 17, 2026
Supporting the designation of April 10 as "Dolores Huerta Day", in honor of the accomplishments and legacy of the trailblazing labor and civil rights leader Dolores Huerta.
Bill HRES 1170April 17, 2026
A resolution designating April 2026 as "Second Chance Month".
Bill SRES 668April 17, 2026
SAT Streamlining Act
Bill HR 8255April 17, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to "William D. Ford Federal Direct Loan (Direct Loan) Program".
Bill SJRES 182April 17, 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to "William D. Ford Federal Direct Loan (Direct Loan) Program".
Bill HJRES 155April 17, 2026
Safer Roads for Those Who Serve Act of 2026
Bill S 4245April 17, 2026
Western Refined Fuel Reserve Act of 2026
Bill HR 8204April 17, 2026


